Skip to main content
. 2017 Aug 18;8(62):104813–104830. doi: 10.18632/oncotarget.20338

Figure 9. Lamin B2 and MCM7 expression in clinical NSCLC samples.

Figure 9

(A) Immunohistochemical analysis of lamin B2 and MCM7 expression in NSCLC tissue samples. Red arrows point to nuclear laminB2 staining in (a) normal bronchial epithelium, (c) poorly-differentiated lung adenocarcinoma (e) poorly-differentiated squamous cell lung carcinoma and nuclear MCM7 expression in (b) normal bronchial epithelium, (d) poorly-differentiated lung adenocarcinoma, (f) poorly-differentiated squamous cell lung carcinoma. (B) Kaplan Meier survival curves show the overall survival rates in 150 NSCLC patients based on low and high laminB2 (left) and MCM7 (right). As shown, high laminB2 and MCM7 expressing patients had poor survival rates than low laminB2 and MCM7 expressing patients.